Roche Ticlid-Associated TTP Could Be 1 in 2,000-4,000 Patients - Labeling
Executive Summary
"The incidence of ticlopidine-associated [thrombotic thrombocytopenic purpura] may be as high as one case in every 2,000 to 4,000 patients exposed," new language in a boxed warning for Roche's Ticlid states.